Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. LFTO
2. CMCSA
3. QNT
4. VRDN
5. NVDA
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026
(NASDAQ: SYRE) Delayed: 90.16 +2.27 (2.58%)
Previous Close $87.89    52 Week High $ 
Open $86.56    52 Week Low $ 
Day High $90.90    P/E N/A 
Day Low $84.81    EPS $ 
Volume 2,014,817